554 related articles for article (PubMed ID: 22683540)
21. Analytical characterization of IgG Fc subclass variants through high-resolution separation combined with multiple LC-MS identification.
He XA; Washburn N; Arevalo E; Robblee JH
Anal Bioanal Chem; 2015 Sep; 407(23):7055-66. PubMed ID: 26231686
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
[TBL] [Abstract][Full Text] [Related]
23. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.
Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ
J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289
[TBL] [Abstract][Full Text] [Related]
24. Naturally occurring glycan forms of human immunoglobulins G1 and G2.
Flynn GC; Chen X; Liu YD; Shah B; Zhang Z
Mol Immunol; 2010 Jul; 47(11-12):2074-82. PubMed ID: 20444501
[TBL] [Abstract][Full Text] [Related]
25. Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals.
Edri-Brami M; Sharoni H; Hayoun D; Skutelsky L; Nemirovsky A; Porgador A; Lichtenstein RG
Exp Neurol; 2015 May; 267():95-106. PubMed ID: 25725350
[TBL] [Abstract][Full Text] [Related]
26. Effect of Fc-Glycan Structure on the Conformational Stability of IgG Revealed by Hydrogen/Deuterium Exchange and Limited Proteolysis.
Fang J; Richardson J; Du Z; Zhang Z
Biochemistry; 2016 Feb; 55(6):860-8. PubMed ID: 26812426
[TBL] [Abstract][Full Text] [Related]
27. The enzymatic removal of immunoglobulin variable domain glycans by different glycosidases.
van de Bovenkamp FS; Derksen NIL; Ooijevaar-de Heer P; Rispens T
J Immunol Methods; 2019 Apr; 467():58-62. PubMed ID: 30742813
[TBL] [Abstract][Full Text] [Related]
28. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
Raju TS
Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
[TBL] [Abstract][Full Text] [Related]
29. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
Goetze AM; Liu YD; Zhang Z; Shah B; Lee E; Bondarenko PV; Flynn GC
Glycobiology; 2011 Jul; 21(7):949-59. PubMed ID: 21421994
[TBL] [Abstract][Full Text] [Related]
30. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody.
Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652
[TBL] [Abstract][Full Text] [Related]
31. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.
Holland M; Yagi H; Takahashi N; Kato K; Savage CO; Goodall DM; Jefferis R
Biochim Biophys Acta; 2006 Apr; 1760(4):669-77. PubMed ID: 16413679
[TBL] [Abstract][Full Text] [Related]
32. Cleavage of IgG by elastase-like protease (ELP) of human polymorphonuclear leukocytes (PMN): isolation and characterization of Fab and Fc fragments and low-molecular-weight peptides. Stimulation of granulocyte function by ELP-derived Fab and Fc fragments.
Kolb G; Köppler H; Gramse M; Havemann K
Immunobiology; 1982 May; 161(5):507-23. PubMed ID: 7047381
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G.
Fokkink WJ; Falck D; Santbergen TC; Huizinga R; Wuhrer M; Jacobs BC
PLoS One; 2015; 10(10):e0139828. PubMed ID: 26457892
[TBL] [Abstract][Full Text] [Related]
34. Measurement of Neutral and Sialylated IgG N-Glycome at Asn-297 by CE-LIF to Assess Hypogalactosylation in Rheumatoid Arthritis.
Schwedler C; Blanchard V
Methods Mol Biol; 2019; 1972():77-93. PubMed ID: 30847785
[TBL] [Abstract][Full Text] [Related]
35. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.
Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F
MAbs; 2015; 7(5):863-70. PubMed ID: 26067753
[TBL] [Abstract][Full Text] [Related]
36. Limited enzymatic cleavage of pig immunoglobulin G and of specific antibodies. III. Large-scale isolation of tryptic fragments of antibodies and of non-specific immunoglobulin and characteristics of the Fc fragment.
Olsovská Z; Franĕk F
Folia Biol (Praha); 1983; 29(6):385-402. PubMed ID: 6667743
[TBL] [Abstract][Full Text] [Related]
37. In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.
Warnock D; Bai X; Autote K; Gonzales J; Kinealy K; Yan B; Qian J; Stevenson T; Zopf D; Bayer RJ
Biotechnol Bioeng; 2005 Dec; 92(7):831-42. PubMed ID: 16187338
[TBL] [Abstract][Full Text] [Related]
38. The effect of Fc glycan forms on human IgG2 antibody clearance in humans.
Chen X; Liu YD; Flynn GC
Glycobiology; 2009 Mar; 19(3):240-9. PubMed ID: 18974198
[TBL] [Abstract][Full Text] [Related]
39. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494
[TBL] [Abstract][Full Text] [Related]
40. Lectin analysis of human immunoglobulin G N-glycan sialylation.
Dalziel M; McFarlane I; Axford JS
Glycoconj J; 1999 Dec; 16(12):801-7. PubMed ID: 11133020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
